INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 128 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $338,837 | -13.5% | 871,047 | -0.7% | 0.00% | – |
| Q2 2023 | $391,780 | -98.3% | 877,447 | -96.9% | 0.00% | -100.0% |
| Q1 2023 | $22,888,152 | -76.7% | 27,912,380 | -55.7% | 0.00% | -66.7% |
| Q4 2022 | $98,193,738 | +118.7% | 62,944,704 | +141.9% | 0.00% | 0.0% |
| Q3 2022 | $44,895,000 | -19.4% | 26,025,967 | -19.2% | 0.00% | 0.0% |
| Q2 2022 | $55,699,000 | -33.3% | 32,195,674 | +38.4% | 0.00% | -25.0% |
| Q1 2022 | $83,532,000 | +25.9% | 23,267,928 | +74.9% | 0.00% | +33.3% |
| Q4 2021 | $66,369,000 | -15.3% | 13,300,430 | +21.5% | 0.00% | -25.0% |
| Q3 2021 | $78,382,000 | -5.1% | 10,947,266 | +22.9% | 0.00% | 0.0% |
| Q2 2021 | $82,569,000 | +7.8% | 8,907,158 | +7.9% | 0.00% | 0.0% |
| Q1 2021 | $76,611,000 | -2.7% | 8,255,537 | -7.2% | 0.00% | -20.0% |
| Q4 2020 | $78,717,000 | -15.2% | 8,894,555 | +11.2% | 0.01% | -16.7% |
| Q3 2020 | $92,816,000 | -51.3% | 8,001,420 | +13.2% | 0.01% | -57.1% |
| Q2 2020 | $190,501,000 | +1375.3% | 7,068,695 | +307.3% | 0.01% | +1300.0% |
| Q1 2020 | $12,913,000 | +146.9% | 1,735,565 | +9.5% | 0.00% | – |
| Q4 2019 | $5,231,000 | +46.3% | 1,585,144 | -9.1% | 0.00% | – |
| Q3 2019 | $3,576,000 | -30.0% | 1,744,448 | +0.4% | 0.00% | – |
| Q2 2019 | $5,108,000 | -67.3% | 1,737,450 | -58.5% | 0.00% | -100.0% |
| Q1 2019 | $15,618,000 | +15.9% | 4,187,183 | +24.3% | 0.00% | 0.0% |
| Q4 2018 | $13,474,000 | -21.4% | 3,368,559 | +9.3% | 0.00% | 0.0% |
| Q3 2018 | $17,133,000 | +11.5% | 3,081,624 | -21.4% | 0.00% | 0.0% |
| Q2 2018 | $15,368,000 | -27.0% | 3,920,321 | -12.3% | 0.00% | -50.0% |
| Q1 2018 | $21,058,000 | +27.2% | 4,470,972 | +11.6% | 0.00% | +100.0% |
| Q4 2017 | $16,553,000 | -30.5% | 4,008,002 | +6.6% | 0.00% | -50.0% |
| Q3 2017 | $23,827,000 | +40.2% | 3,758,315 | +73.4% | 0.00% | 0.0% |
| Q2 2017 | $17,000,000 | +2.6% | 2,168,029 | -13.3% | 0.00% | +100.0% |
| Q1 2017 | $16,562,000 | -6.3% | 2,501,710 | -1.8% | 0.00% | -50.0% |
| Q4 2016 | $17,676,000 | -36.4% | 2,547,073 | -14.6% | 0.00% | -33.3% |
| Q3 2016 | $27,784,000 | +20.0% | 2,980,791 | +18.9% | 0.00% | +50.0% |
| Q2 2016 | $23,157,000 | +28.3% | 2,506,096 | +20.9% | 0.00% | 0.0% |
| Q1 2016 | $18,049,000 | +9.9% | 2,072,229 | -15.2% | 0.00% | 0.0% |
| Q4 2015 | $16,424,000 | -36.0% | 2,444,184 | -44.9% | 0.00% | -33.3% |
| Q3 2015 | $25,647,000 | -21.5% | 4,437,855 | +10.8% | 0.00% | 0.0% |
| Q2 2015 | $32,692,000 | -1.4% | 4,006,069 | -1.5% | 0.00% | 0.0% |
| Q1 2015 | $33,173,000 | +24.2% | 4,065,329 | +39.7% | 0.00% | 0.0% |
| Q4 2014 | $26,711,000 | +15.7% | 2,909,545 | +24.1% | 0.00% | +50.0% |
| Q3 2014 | $23,094,000 | -6.9% | 2,344,477 | +2.2% | 0.00% | -33.3% |
| Q2 2014 | $24,809,000 | – | 2,295,070 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 570,049 | $221,749 | 0.17% |
| GMT CAPITAL CORP | 1,513,500 | $588,752 | 0.02% |
| Cedar Brook Financial Partners, LLC | 130,522 | $50,773 | 0.01% |
| Arlington Capital Management, Inc. | 27,735 | $10,789 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 296,948 | $116 | 0.01% |
| Keystone Financial Group | 109,897 | $42,751 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 163,562 | $63,626 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,149,974 | $447,340 | 0.00% |
| Freedom Investment Management, Inc. | 62,298 | $24,234 | 0.00% |
| Renaissance Technologies | 4,889,500 | $1,902 | 0.00% |